Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | PAM | P19021 | 2/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | PPARD | Q03181 | 7/20 | 0.56 |
| ▸ | PPARA | Q07869 | 7/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TLR2 | O60603 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25586645 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL4953486 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL27328460 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL11782956 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL20500786 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL5864565 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL31108662 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL31108674 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL2894214 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 | |
| SCHEMBL27722553 | 0.98 | DGKA (0.68) | DGKANAAAPAMHTR2CGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114929833-B | High thermal conductivity layered phase change composite material | 罗杰斯公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-114929833-A | High-thermal-conductivity layered phase-change composite material | 罗杰斯公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-111989362-B | Plasticizer composition and resin composition comprising the same | 株式会社LG化学 | 2022-06-24 | — | — | CN | disclosed |
| CN-109689792-B | Liquid antioxidant composition for raw rubber | 巴斯夫欧洲公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-3914635-A1 | DIHYDROXY LACTAM BASED POLYMERS, COMPOSITIONS AND APPLICATIONS THEREOF | ISP Investments LLC (US) | 2021-12-01 | — | — | EP | disclosed |
| CN-113631632-A | Dihydroxylactam-based polymers, compositions thereof and uses thereof | ISP投资有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-111989362-A | Plasticizer composition and resin composition comprising the same | 株式会社LG化学 | 2020-11-24 | — | — | CN | disclosed |
| WO-2020154471-A1 | DIHYDROXY LACTAM BASED POLYMERS, COMPOSITIONS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2020-07-30 | — | — | WO | disclosed |
| US-9586917-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | ZEON CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20160280672-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160257659-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC PRODUCT | ZEON CORPORATION (JP) | 2016-09-08 | — | — | US | disclosed |
| US-20160200841-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICAL ANISOTROPIC BODY | ZEON CORPORATION (JP) | 2016-07-14 | — | — | US | disclosed |
| US-20150277010-A1 | PHASE DIFFERENCE PLATE, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | ZEON CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150175564-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2015-06-25 | — | — | US | disclosed |
| CN-103649183-A | Microcapillary films containing phase change materials | DOW GLOBAL TECHNOLOGIES L L C | 2014-03-19 | — | — | CN | disclosed |
| EP-0290211-B1 | DIHYDROPYRIDINES | Pfizer Limited (GB) | 1991-09-04 | — | — | EP | disclosed |
| EP-0290211-A1 | Dihydropyridines | Pfizer Limited (GB) | 1988-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160257659-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC PRODUCT | CCNA1, PYM1, SCO2 | DGKA 3390/4885NAAA 3041/4885PAM 158/4885 |
| US-20160280672-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PYM1, C5, C1S | DGKA 2364/4885NAAA 3226/4885PAM 477/4885 |
| US-20150175564-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PYM1, C5, C1S | DGKA 2364/4885NAAA 3226/4885PAM 477/4885 |
| US-20160200841-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICAL ANISOTROPIC BODY | F12, PYM1, C5 | DGKA 3157/4885NAAA 4297/4885PAM 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.